China’s Mindray Expands Market With Increased R&D And Acquisitions
This article was originally published in PharmAsia News
Executive Summary
Mindray expects to hold its own amidst foreign competition, including in the high-end device market thanks to acquisitions and R&D investments that have boosted its technological capability.